Skip to main content

Find Clinical Trials

Home
Conditions
Pancreatic Diseases

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,387 public trials 842 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer

NCT03699319

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

NCT06789224

Conditions: Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +74 more
Locations: Kliniken der Stadt Köln gGmbH Cologne, North Rhine-Westphalia, Germany

Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie Universitätsklinikum Frankfurt Frankfurt, Germany

Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik für Anästhesiologie Mainz, Germany

Universitätsmedizin Mannheim, Klinik für Urologie und Urochirurgie Mannheim, Germany

View Trial Details

Completed

Functional Analysis by Dynamic Imaging of the Respiratory Epithelium in Infants With Cystic Fibrosis

NCT01605565

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Chu Reims Reims, France

View Trial Details

Completed

Normal Saline Versus Lactated Ringer's Solution for Acute Pancreatitis Resuscitation

NCT05781243

Conditions: Acute Pancreatitis, Digestive System Diseases, Pancreatic Diseases, +1 more
Locations: Dr. Balmis General University Hospital Alicante, Spain

View Trial Details

Completed

Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer

NCT01821612

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States

The James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States

View all 14 locations

View Trial Details

Completed

Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas

NCT03153410

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation

NCT06766786

Conditions: Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus, With Complications, +9 more
Locations: Central Manchester University Hospital Manchester, United Kingdom

View Trial Details

Completed

Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer

NCT02581215

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Mayo Clinic-Arizona Scottsdale, Arizona, United States

Emory University: Winship Cancer Institute Atlanta, Georgia, United States

Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

Community Healthcare System Munster, Indiana, United States

View Trial Details

Completed

Development a Core Set for Adults With Cystic Fibrosis Based on the ICF

NCT06128499

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +5 more
Locations: Hacettepe University Ankara, Altındağ, Turkey (Türkiye)

View Trial Details

Completed

Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients

NCT00677365

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis (CF), +6 more
Locations: Mobile, Alabama, United States

Phoenix, Arizona, United States

Tucson, Arizona, United States

Little Rock, Arkansas, United States

View all 50 locations

View Trial Details